Clinical and biological significance of CD56 antigen expression in acute promyelocytic leukemia

Leukemia and Lymphoma

Volumn 45, Issue 9, 2004, Pages 1783-1789

  Ito, Shigeki ^a   Ishida, Yoji ^a   Oyake, Tatsuo ^a   Satoh, Mamiko ^a   Aoki, Yusei ^a   Kowata, Shugo ^a   Uchiyama, Toshiyuki ^a   Enomoto, Sanae ^a   Sugawara, Takeshi ^a   Numaoka, Hideharu ^a   Suzuki, Keijiro ^a   Murai, Kazunori ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute promyelocytic leukemia; CD34; CD56; Clonal evolution; Extramedullary disease

Indexed keywords

ACLARUBICIN; CD34 ANTIGEN; CD56 ANTIGEN; CYTARABINE; DAUNORUBICIN; ENOCITABINE; ETOPOSIDE; FIBRINOGEN; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; LACTATE DEHYDROGENASE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; RETINOIC ACID; TACROLIMUS;

ADOLESCENT; ADULT; AGE; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW TRANSPLANTATION; BRAIN DISEASE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA REMISSION; LEUKEMOGENESIS; LEUKOCYTE COUNT; MALE; PERFORMANCE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD56; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; RECURRENCE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 3242891691     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190410001683624     Document Type: Article

References (34)

1. Warrell, R.P. Jr. (1996) "Pathogenesis and management of acute promyelocytic leukemia", Annu. Rev. Med., 47, 555-565.
2. Fenaux, P., Chomienne, C. and Degos, L. (1997) "Acute promyelocytic leukemia: Biology and treatment", Semin. Oncol., 24, 92-102.
3. Lo Coco, F., Nervi, C., Avvisati, G. and Mandelli, F. (1998) "Acute promyelocytic leukemia: A curable disease", Leukemia, 12, 1866-1880.
4. Chou, W.C., Tang, J.L., Yao, M., Liang, Y.J., Lee, F.Y., Lin, M.T., et al. (1997) "Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: A high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment", Leukemia, 11, 921-928.
5. Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., et al. (1999) "A randomized comparison of ATRA followed by chemotherapy and ATRA plus chemotherapy, and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia" , Blood, 94, 1192-1200.
6. Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Ogden, A., et al. (1997) "All-trans retinoic acid in acute promyelocytic leukemia", N. Engl. J. Med., 337, 1021-1028.
7. Asou, N., Adachi, K., Tamura, J., Kanamaru, A., Kageyama, S., Hiraoka, A., et al. (1998) Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy: Japan Adult Leukemia Study Group", J. Clin. Oncol., 16, 78-85.
8. Burnett, A.K., Grimwade, D., Solomon, E., Wheatley, K. and Goldstone, A.H. (1999) "Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Results of the Randomized MRC trial", Blood, 93, 4131-4143.
9. Ferrara, F., Morabito, F., Martino, B., Specchia, G., Liso, V., Nobile, F., et al. (2000) "CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans retinoic acid and chemotherapy" , J. Clin. Oncol., 18, 1295-1300.
10. Bear, M.R., Stewart, C.C., Lawrence, D., Arthur, D.C., Byrd, J.C., Davey, F.R., et al. (1997) "Expression of the neural adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22)", Blood, 90, 1643-1648.
11. Murray, C.K., Estey, E., Paietta, E., Howard, R.S., Edenfield, W.J., Pierce, S., et al. (1999) "CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?", J. Clin. Oncol., 17, 293-297.
12. Di Bona, E., Sartori, R., Zambello, R., Guercini, N., Madeo, D. and Rodeghiero, F. (2002) "Prognostic significance of CD56 antigen expression in acute leukemia", Hematologica, 87, 250-256.
13. Byrd, J.C., Weiss, R.B., Arthur, D.C., Lawrence, D., Baer, M.R., Davey, F., et al. (1997) "Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461", J. Clin. Oncol., 15, 466-475.
14. Byrd, J.C., Edenfield, W.J., Shields, D.S. and Dawson, N.A. (1995) "Extramedullary myeloid tumors in acute nonlymphocytic leukemia: A clinical review", J. Clin. Oncol., 13, 1800-1816.
15. Tallman, M.S., Hakimian, D., Shaw, J.M., Lissner, G.S., Russell, E.J. and Variakojis, D. (1995) "Granulocytic sarcoma is associated with the t(8;21) translocation in acute myeloid leukemia" , J. Clin. Oncol., 11, 690-697.
16. Seymour, J.F., Pierce, S.A., Kantarjan, H.M., Keating, M.J. and Estey, E.H. (1994) "Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56)", Leukemia, 8, 823-826.
17. Liso, V., Specchia, G., Pogliani, E.M., Palumbo, G., Mininni, D., Rossi, V., et al. (1998) "Extramedullary involvement in patients with acute promyelocytic leukemia", Cancer, 83, 1522-1528.
18. Guglielmi, C., Wartelli, M.P., Diverio, D., Fenu, S., Vegna, M.L., Cantu-Rajnoldi, A., et al. (1998) "Immunophenotype of adult and childhood acute promyelocytic leukemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases", Br. J. Haematol., 102, 1035-1041.
19. Piedras, J., Lopez-Karpovitch, X. and Cardenas, R. (1998) "Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant", Cytometry, 32, 286-290.
20. Exner, M., Thalhammer, R., Kapiotis, S., Mitterbauer, G., Knobl, P., Haas, O.A., et al. (2000) "The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?", Cytometry, 42, 106-109.
21. Edward, R.H., Wasik, M.A., Finan, J., Rodriguez, R., Moore, J., Kamoun, M., et al. (1999) "Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia", Am. J. Clin. Pathol., 112, 819-827.
22. + relapsed acute promyelocytic leukemia" , Am. J. Hematol., 69, 59-63.
23. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., et al. (1985) "Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group", Ann. Intern. Med., 103, 620-625.
24. Ito, S., Ishida, Y., Murai, K. and Kuriya, S. (2001) "Flow cytometric analysis of aberrant antigen expression of blasts using CD45 blast gating for minimal residual disease in acute leukemia and high-risk myelodysplastic syndrome", Leak. Res., 25, 205-211.
25. Byrd, J.C., Weiss, R.B., Arthur, D.C., Lawrence, D., Baer, M.R., Davey, F., et al. (1997) "Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): Results from Cancer and Leukemia Group B 8461", J. Clin. Oncol., 15, 466-475.
26. Cheson, B.D., Cassileth, P.A., Head, D.R., Schiffer, C.A., Bennett, J.M., Bloomfield, C.D., et al. (1990) "Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia", J. Clin. Oncol., 8, 813-819.
27. Kaplan, E.L. and Meier, P. (1958) "Nonparametric estimation from incomplete observation", J. Am. Stat. Assoc., 53, 457-481.
28. Estey, E., Thall, P.F., Pierce, S., Kantarjian, H. and Keating, M. (1997) "Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine", J. Clin. Oncol., 15, 483-490.
29. Vahdat, L., Maslak, P., Miller, W.H. Jr., Eardley, A., Heller, G., Scheinberg, D.A., et al. (1994) "Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PML/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid", Blood, 84, 3843-3849.
30. Slack, J.L., Arthur, D.C., Lawrence, D., Mrozek, K., Mayer, R.J., Davey, F.R., et al. (1997) "Secondary cytogenetic changes in acute promyelocytic leukemia: Prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene-A Cancer and Leukemia Group B study", J. Clin. Oncol., 15, 1786-1795.
31. + t(8;21) AML blasts: further suggestion of the adverse clinical significance of this biological marker?", Br. J. Haematol., 107, 381-383.
32. Gallagher, R.E., Yeap, B.Y., Bi, W., Livak, K.J., Beaubier, N., Rao, S., et al. (2003) "Qantitative real-time RT-PCR analysis of PML-RARα mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129", Blood, 101, 2521-2528.
33. + myeloid/natural killer cell precursor acute leukemia: A distinct hematolymphoid disease entity", Blood, 90, 2417-2428.
34. - myeloid/natural killer cell acute leukemia: a previous unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3", Blood, 84, 244-255.